These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8848820

  • 21. Digoxin-quinidine interaction in patients with renal failure.
    Hirschberg R, Schaefer K, von Herrath D, Kreutz G, Kewitz H.
    Klin Wochenschr; 1981 May 15; 59(10):521-2. PubMed ID: 7241953
    [Abstract] [Full Text] [Related]

  • 22. Comparative effects of verapamil and isradipine on steady-state digoxin kinetics.
    Rodin SM, Johnson BF, Wilson J, Ritchie P, Johnson J.
    Clin Pharmacol Ther; 1988 Jun 15; 43(6):668-72. PubMed ID: 2967742
    [Abstract] [Full Text] [Related]

  • 23. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T.
    J Clin Pharmacol; 1997 Feb 15; 37(2):92-100. PubMed ID: 9055134
    [Abstract] [Full Text] [Related]

  • 24. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    Drugs Aging; 2011 Oct 01; 28(10):831-41. PubMed ID: 21970310
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic interactions with digoxin.
    Rodin SM, Johnson BF.
    Clin Pharmacokinet; 1988 Oct 01; 15(4):227-44. PubMed ID: 3056649
    [Abstract] [Full Text] [Related]

  • 26. Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.
    Dahlqvist R, Ejvinsson G, Schenck-Gustafsson K.
    Br J Clin Pharmacol; 1980 Apr 01; 9(4):413-8. PubMed ID: 7378258
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.
    Antman EM, Arnold JM, Friedman PL, Smith TW.
    Cardiovasc Drugs Ther; 1987 Aug 01; 1(2):183-9. PubMed ID: 3154322
    [Abstract] [Full Text] [Related]

  • 28. Population pharmacokinetics of quinidine.
    Fattinger K, Vozeh S, Ha HR, Borner M, Follath F.
    Br J Clin Pharmacol; 1991 Mar 01; 31(3):279-86. PubMed ID: 2054269
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K, Dahlqvist R.
    Br J Clin Pharmacol; 1981 Feb 01; 11(2):181-6. PubMed ID: 7213521
    [Abstract] [Full Text] [Related]

  • 30. Hepatic interaction between quinidine and digoxin: role of inhibition of sinusoidal Na⁺/K⁺ ATPase digoxin binding.
    Li P, Weiss M, Roberts MS.
    Eur J Pharm Sci; 2012 Sep 29; 47(2):506-11. PubMed ID: 22820029
    [Abstract] [Full Text] [Related]

  • 31. The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics.
    Johnson BF, Wilson J, Marwaha R, Hoch K, Johnson J.
    Clin Pharmacol Ther; 1987 Jul 29; 42(1):66-71. PubMed ID: 2954736
    [Abstract] [Full Text] [Related]

  • 32. Quinidine reduces biliary clearance of digoxin in man.
    Angelin B, Arvidsson A, Dahlqvist R, Hedman A, Schenck-Gustafsson K.
    Eur J Clin Invest; 1987 Jun 29; 17(3):262-5. PubMed ID: 3113970
    [Abstract] [Full Text] [Related]

  • 33. Digoxin-quinidine-spironolactone interaction.
    Fenster PE, Hager WD, Goodman MM.
    Clin Pharmacol Ther; 1984 Jul 29; 36(1):70-3. PubMed ID: 6734052
    [Abstract] [Full Text] [Related]

  • 34. Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humans.
    Hedman A, Angelin B, Arvidsson A, Beck O, Dahlqvist R, Nilsson B, Olsson M, Schenck-Gustafsson K.
    Clin Pharmacol Ther; 1991 Mar 29; 49(3):256-62. PubMed ID: 2007320
    [Abstract] [Full Text] [Related]

  • 35. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.
    Dagenais C, Zong J, Ducharme J, Pollack GM.
    Pharm Res; 2001 Jul 29; 18(7):957-63. PubMed ID: 11496955
    [Abstract] [Full Text] [Related]

  • 36. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
    Macha S, Sennewald R, Rose P, Schoene K, Pinnetti S, Woerle HJ, Broedl UC.
    Clin Ther; 2013 Mar 29; 35(3):226-35. PubMed ID: 23497760
    [Abstract] [Full Text] [Related]

  • 37. Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration.
    Rey AM, Gums JG.
    DICP; 1991 Mar 29; 25(7-8):745-6. PubMed ID: 1949932
    [Abstract] [Full Text] [Related]

  • 38. [Interaction between calcium antagonists and digoxin].
    Christensen C.
    Ugeskr Laeger; 1991 Apr 22; 153(17):1180-4. PubMed ID: 2028527
    [Abstract] [Full Text] [Related]

  • 39. Quinidine administration increases steady state serum digoxin concentration in horses.
    Parraga ME, Kittleson MD, Drake CM.
    Equine Vet J Suppl; 1995 Sep 22; (19):114-9. PubMed ID: 8933078
    [Abstract] [Full Text] [Related]

  • 40. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.
    Fujii S, Setoguchi C, Kawazu K, Hosoya K.
    Invest Ophthalmol Vis Sci; 2014 Jul 01; 55(7):4650-8. PubMed ID: 24985475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.